ACTA1 and Hepatic fibrosis: In addition, indicators of hepatic fibrosis, such as Col1αI and α-SMA, were significantly reduced in mice treated with FT@XBP1 compared with FFC diet-fed mice, as demonstrated by Western blot analysis (Figure 4P).